Brand Name Drug Companies See Soaring Profits After Hiking Prices Today, brand name drug giants AstraZeneca and Eli Lilly announced rising profits for the second quarter of 2020 – topping analysts’ expectations. AstraZeneca AstraZeneca reported a net profit of $756 million, up from $130 million for the same period a year earlier. Sales rose eight […]
Big Pharma Giant Sees Profits Jump After July Price Hikes Big Pharma giant Sanofi topped earnings expectations while continuing to hike prices, new second-quarter earnings show. Sanofi beat earnings expectations this quarter and reported a net profit jump to $8.9 billion. Strong growth this quarter was driven by eczema and asthma drug Dupixent. Strong Q2 […]
Brand Name Big Pharma Giants Surpass Expectations After Hiking Prices New second quarter earnings reports released yesterday from Big Pharma giants Pfizer and Amgen demonstrate yet again that price hikes continue to support big time profits for brand name drug companies. Both pharmaceutical manufacturers beat Wall Street expectations for the second quarter of 2020. Pfizer […]
Reception of Misguided Reboot Focuses on Premium Increases, Cost to Taxpayers, Support from Drug Companies and Poison Pill Provision On Friday, the administration announced the revival of a policy known as the Rebate Rule via executive order. The Rebate Rule was previously withdrawn by the White House amid concerns that the measure would hike premiums […]
HHS Secretary, Republican Lawmakers, Right-of-Center Policy Experts and Conservative Commentators Raised Doubts on Premium Increases, Cost to Taxpayers and Bailout for Big Pharma Reports this week indicate the administration may reboot a policy known as the Rebate Rule. The Rebate Rule was previously withdrawn by the White House amid concerns, on both sides of the […]
Brand Name Drug Company Beats Earnings Forecasts After Repeatedly Hiking Prices New earnings reports for the second quarter of 2020 show that Big Pharma giants are continuing to rake in profits while hiking prescription drug prices. On Tuesday, Big Pharma drug company Novartis announced it bested earnings forecasts for the second quarter after hiking prices […]
AMERICAN VOTERS OVERWHELMINGLY SUPPORT MARKET-BASED SOLUTIONS TO HOLD DRUG COMPANIES ACCOUNTABLE, OPPOSE ADDITIONAL INCENTIVES FOR R&D COVID-19 AND THE CRISIS OF PRESCRIPTION DRUG PRICES Before the COVID-19 crisis, more than 58 million Americans struggled to afford their prescription drugs. Now, the economic impact of the pandemic continues to leave millions more American workers, families […]
Price Hikes Fuel Q2 Earnings Beat For Brand Name Giant As millions of Americans continue to grapple with the economic impact of the COVD-19 pandemic, the first earnings report for the second quarter of 2020 from a Big Pharma giant demonstrates that hiking prices on American patients continues to be a profitable practice for the […]
Big Pharma Must Suspend Summer Price Hikes Amid Historic Economic Uncertainty By Lauren Aronson Morning Consult June 23, 2020 Before the COVID-19 crisis, more than 58 million Americans struggled to afford their medications. Now, the economic impact of the pandemic has left millions more American workers, families and seniors struggling just to stay afloat. Prior to the historic economic […]
Coalition Applauds Positive Step from the Administration to Lower Insulin Prices, Encourages Additional Action to Hold Drug Companies Accountable Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) welcomed the announcement of a public-private partnership to help lower insulin prices for Medicare beneficiaries Tuesday. The move from the administration will create Medicare Part D […]